Global Microbiology Testing/Clinical Microbiology Market is Set for a Positive Growth Forecast at CAGR of 6.4% till 2023
Bharat Book Bureau Provides the Trending Market Research Report on “Global Microbiology Testing/Clinical Microbiology Market, Forecast to 2023” under Life Sciences category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.
Global Clinical Microbiology Market is projected to grow at a CAGR of 6.4% in the next five years
The global clinical microbiology market is projected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4% from 2018 to 2023. Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation. However, factors such as reimbursement concerns and unfavorable regulatory scenario are restraining the growth of this market to a certain extent.
Request a free sample copy of Microbiology Testing/Clinical Microbiology Market Report @ https://www.bharatbook.com/MarketReports/Sample/Reports/168638
The reagents segment is projected to grow at the highest CAGR during the forecast period
By product, the clinical microbiology market is classified into instruments (laboratory instruments and microbiology analyzers) and reagents (pathogen-specific kits and general reagents). In 2018, the instruments product segment accounted for the largest share of the market, however, the reagents product segment is expected to grow at a higher rate during the forecast period. The growth of the reagents segment can be attributed to the high prevalence of infectious diseases across major markets, growing trend of reagent rental agreements along with instrument sales, and the increasing number of life science researches in the field of pathogen-specific reagents.
Asia Pacific to witness the highest growth during the forecast period (2018-2023)
North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period. Factors such as the growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence and prevalence of infectious diseases in the region.
Break-up of primary participants was as mentioned below:
- By Company Type – Tier 1–33%, Tier 2–46% and Tier 3–21%
- By Designation – C-level–26%, Director Level–20%, Others–54%
- By Region – North America–33%, Europe–29%, Asia Pacific–24%, RoW–14%
Note: RoW includes Latin America and the Middle East & Africa
Some of the major market players in the microbiology testing/clinical microbiology market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.
Click the link below to read the Full report :
https://www.bharatbook.com/MarketReports/Microbiology-TestingClinical-Microbiology-Market-by-Application-Pharma-Clinical-Manufacturing-Environment-Disease-Respir/168638
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, LinkedIn, Google Plus
Global Clinical Microbiology Market is projected to grow at a CAGR of 6.4% in the next five years
The global clinical microbiology market is projected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4% from 2018 to 2023. Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation. However, factors such as reimbursement concerns and unfavorable regulatory scenario are restraining the growth of this market to a certain extent.
Request a free sample copy of Microbiology Testing/Clinical Microbiology Market Report @ https://www.bharatbook.com/MarketReports/Sample/Reports/168638
The reagents segment is projected to grow at the highest CAGR during the forecast period
By product, the clinical microbiology market is classified into instruments (laboratory instruments and microbiology analyzers) and reagents (pathogen-specific kits and general reagents). In 2018, the instruments product segment accounted for the largest share of the market, however, the reagents product segment is expected to grow at a higher rate during the forecast period. The growth of the reagents segment can be attributed to the high prevalence of infectious diseases across major markets, growing trend of reagent rental agreements along with instrument sales, and the increasing number of life science researches in the field of pathogen-specific reagents.
Asia Pacific to witness the highest growth during the forecast period (2018-2023)
North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period. Factors such as the growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence and prevalence of infectious diseases in the region.
Break-up of primary participants was as mentioned below:
- By Company Type – Tier 1–33%, Tier 2–46% and Tier 3–21%
- By Designation – C-level–26%, Director Level–20%, Others–54%
- By Region – North America–33%, Europe–29%, Asia Pacific–24%, RoW–14%
Note: RoW includes Latin America and the Middle East & Africa
Some of the major market players in the microbiology testing/clinical microbiology market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.
Click the link below to read the Full report :
https://www.bharatbook.com/MarketReports/Microbiology-TestingClinical-Microbiology-Market-by-Application-Pharma-Clinical-Manufacturing-Environment-Disease-Respir/168638
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, LinkedIn, Google Plus
Comments
Post a Comment